Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Patients should always follow the prescription label and instructions from their licensed healthcare provider
Compounded semaglutide is not FDA approved and has not been evaluated by the FDA for safety, effectiveness, or manufacturing quality
Retatrutide is an investigational once-weekly injectable triple receptor agonist that activates GLP-1, GIP, and glucagon receptors simultaneously, producing greater appetite suppression and energy expenditure than single or dual receptor agonists
Here's How Weight-Loss
US$ 21.23
US$ 27.32
US$ 20.02
US$ 25.42
US$ 29.60
US$ 26.28
US$ 24.04
